Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China

Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance

(2011) Hui-Young Lee et al.   HEPATOLOGY

Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis

(2011) Akio Kawakami et al.   Journal of Atherosclerosis and Thrombosis

Complexities of plasma apolipoprotein C-III metabolism: Fig. 1.

(2011) Frank M. Sacks et al.   JOURNAL OF LIPID RESEARCH

Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans

(2011) Federica Sentinelli et al.   Lipids in Health and Disease

Apolipoprotein CIII Induces Monocyte Chemoattractant Protein-1 and Interleukin 6 Expression Via Toll-Like Receptor 2 Pathway in Mouse Adipocytes: Retracted

(2010) Yasuko Abe et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

APOC3 deficiency: from mice to man

(2009) Marten H Hofker   EUROPEAN JOURNAL OF HUMAN GENETICS

Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation

(2009) O. OLIVIERI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells

(2009) E-ri M Sol et al.   Lipids in Health and Disease

Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction

(2008) Akio Kawakami et al.   CIRCULATION

Increased Plasma Apolipoprotein C-III Concentration Independently Predicts Cardiovascular Mortality: The Hoorn Study

(2008) P. G. Scheffer et al.   CLINICAL CHEMISTRY

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

(2008) D. C. Chan et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

(2008) T. I. Pollin et al.   SCIENCE